{"disease":{"id":"prostate-cancer-metastatic-disease","name":"prostate cancer metastatic disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05352178","title":"Metastasis-directed Therapy for Oligorecurrent Prostate Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":873,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT07004582","title":"Lab Research Using Mini-tumors to Study Prostate Cancer Treatments","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Maastricht Radiation Oncology","has_results":false},{"nct_id":"NCT06430411","title":"Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT06462963","title":"OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)","phase":"NA","overall_status":"RECRUITING","enrollment_count":302,"lead_sponsor_name":"European Organisation for Research and Treatment of Cancer - EORTC","has_results":false},{"nct_id":"NCT06883474","title":"Osteosclerotic Changes on CT Predict Survival in Prostate Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":211,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06832774","title":"Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":192,"lead_sponsor_name":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT06718647","title":"Efficacy and Tolerability of Low-Dose Enzalutamide in Prostate Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Monica Boitano","has_results":false},{"nct_id":"NCT06992232","title":"Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":144,"lead_sponsor_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","has_results":false},{"nct_id":"NCT05223803","title":"TERPS Trial for de Novo Oligometastic Prostate Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":122,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false},{"nct_id":"NCT07333976","title":"o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Tri-Service General Hospital","has_results":false},{"nct_id":"NCT06738745","title":"Study of HRS-2189 Combined HRS-5041 in Prostate Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06212583","title":"High-Risk Metachronous Oligometastatic Prostate Cancer Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":88,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false},{"nct_id":"NCT05413850","title":"Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":82,"lead_sponsor_name":"Blue Earth Therapeutics Ltd","has_results":false},{"nct_id":"NCT06682390","title":"Role of Race in Nutritional Approach in Men on ADT","phase":"NA","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT07115914","title":"PSMA PET for Surveillance After Focal Therapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":62,"lead_sponsor_name":"University of Chicago","has_results":false},{"nct_id":"NCT06957691","title":"Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Shehzad Basaria, M.D.","has_results":false},{"nct_id":"NCT05183074","title":"MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT06915714","title":"The Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04249947","title":"P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":40,"lead_sponsor_name":"Poseida Therapeutics, Inc.","has_results":false},{"nct_id":"NCT07038304","title":"The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":35,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT05188911","title":"Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA Trial","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06840535","title":"A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Philogen S.p.A.","has_results":false},{"nct_id":"NCT06978296","title":"HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS)","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":18,"lead_sponsor_name":"Institut Cancerologie de l'Ouest","has_results":false}],"total":23},"guidelines":[],"source":"Drug Landscape verified database"}